Annexin-A1: Therapeutic Potential in Microvascular Disease.

Purvis, Gareth S D; Solito, Egle; Thiemermann, Christoph

Purvis, Gareth S D; Solito, Egle; Thiemermann, Christoph.

Affiliation

Purvis GSD; William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Solito E; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Thiemermann C; William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Front Immunol ; 10: 938, 2019.

Article in En | MEDLINE | ID: mdl-31114582

Subject(s)

Annexin A1/immunology; Receptors, Formyl Peptide/immunology; Receptors, Lipoxin/immunology; Vascular Diseases/immunology; Addison Disease/drug therapy; Addison Disease/immunology; Addison Disease/pathology; Animals; Cushing Syndrome/drug therapy; Cushing Syndrome/immunology; Cushing Syndrome/pathology; Diabetes Mellitus/drug therapy; Diabetes Mellitus/immunology; Diabetes Mellitus/pathology; Glucocorticoids/immunology; Glucocorticoids/therapeutic use; Humans; Inflammation/drug therapy; Inflammation/immunology; Inflammation/pathology; Vascular Diseases/drug therapy; Vascular Diseases/pathology

Key words

Annexin-A1 (ANXA1); diabetes; inflammation; signaling; tissue protection

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Diseases / Annexin A1 / Receptors, Lipoxin / Receptors, Formyl Peptide Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google